SELLAS Life Sciences Group, Inc. (SLS)

14.10 -0.22 (-1.57%) USD  |  NASDAQ  |  Aug 25, 16:00
14.10 0.00 (0.00%) After-Hours: 16:31
More

SELLAS Life Sciences Group Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 12, 2026 --
July 08, 2026 --
May 13, 2026 --
April 22, 2026 --
March 23, 2026 --
March 20, 2026 --
March 12, 2026 --
December 31, 2025 --
December 30, 2025 --
November 13, 2025 --
August 21, 2025 --
August 13, 2025 --
Date Value
July 15, 2025 --
June 17, 2025 --
May 26, 2025 --
May 14, 2025 --
March 21, 2025 --
November 22, 2024 --
August 14, 2024 --
June 20, 2024 --
May 16, 2024 --
April 01, 2024 --
February 14, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Savara, Inc. Upgrade
Lite Strategy, Inc. Upgrade
AbbVie, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
Rezolute, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade